Stock listing

KURA Stock Price, News, Filings & Events — Kura Oncology, Inc.

Selected listing: KURA · NASDAQ · USD · US

This page tracks Kura Oncology, Inc.'s KURA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KURA:NASDAQ. KURA:NASDAQ is the stock-level entry point for investors researching Kura Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kura Oncology, Inc. is a public company traded under the ticker KURA on the American market. The company has a market capitalization of approximately $922.4 million. Kura focuses on developing innovative therapies for cancer treatment.

KURA:NASDAQUSDUSUpdated August 28, 2026
Kura Oncology, Inc. logo
Ticker
KURA:NASDAQ
Asset type
Stock
Market cap
$1.13B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Kura Oncology, Inc. KURA:NASDAQ stock context

This page tracks Kura Oncology, Inc.'s KURA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KURA:NASDAQ. KURA:NASDAQ is the stock-level entry point for investors researching Kura Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kura Oncology, Inc. is a public company traded under the ticker KURA on the American market. The company has a market capitalization of approximately $922.4 million. Kura focuses on developing innovative therapies for cancer treatment.

Latest news from Kura Oncology, Inc.

All Kura Oncology, Inc. news →

Kura Oncology, Inc. earnings calls

Research Kura Oncology, Inc.

Alternate listings